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1. Introduction 
The adhesion of cells to the extracellular matrix (ECM) is a critical requisite to generate cell 
shape, migration, proliferation, differentiation, and gene expression (Geiger & Yamada, 
2011; Papusheva & Heisenberg, 2010). Beyond this role, cell-ECM adhesion promotes 
various intracellular signalling pathways and effectors modulating cell survival or apoptosis 
and tumor growth (Geiger & Yamada, 2011). Cells use a number of different cell surface 
receptors that mediate cell-ECM adhesion, being one of the best studied the integrins (Jean 
et al., 2011; Schwartz, 2010). It is known that binding of integrins to their ligands is 
dependent on the presence of divalent cations including Ca2+, Mg2+, and Mn2+ (Cierniewska-
Cieslak et al., 2002; Cluzel et al., 2005; Leitinger et al., 2000; Luo & Springer, 2006). These 
heterodimeric transmembrane proteins which lack intrinsic enzymatic activity, in addition 
to being considered as indispensable to mediate cell-ECM adhesion, promote the assembly 
of cell-to-cell adhesion also promote receptor tyrosine kinase (RTK) activation triggering 
signalling cascades that regulate cell growth, proliferation and control cell death. Of note, 
growth factors that activate RTK may also modulate some of the cellular events that are 
mediated by integrins (Streuli & Akhtar, 2009). Now, it is clear that binding of certain 
integrins to their ligands as well as mechanical stimuli including shear stress, compression 
and tensile forces, promotes integrin clustering and that clustered integrins provoke 
recruitment and activation of other signalling molecules, including the RTKs, and therefore 
controlling cell survival, proliferation and migration (Guo & Giancotti, 2004; Ivaska and 
Heino, 2010; Streuli & Akhtar, 2009; Yamada & Even-Ram, 2002). Interestingly, functional 
cooperation between integrins and RTKs is actually considered as critical during normal 
vascular development and in vascular and inflammatory diseases (Eliceiri, 2001; Streuli & 
Akhtar, 2009) as well as in tumor progression and metastasis (Desgrosellier & Cheresh, 2010; 
Guo & Giancotti, 2004). In this context, studies have demonstrated that during cell-ECM 
adhesion some members of the epidermal growth factor (EGF) receptor family such as 
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EGFR/ErbB1 and ErbB2/Neu which has no known ligand, may be partially activated by 
association with particular integrins regulating important cellular functions including 
adhesion, proliferation, differentiation, survival, and migration in the absence of their 
ligands (Bill et al., 2004; Moro et al., 1998). These functions are mediated via upstream and 
downstream signalling pathways. However, the implications of the interactions between 
integrins and RTKs need further investigation.  
Cell-ECM adhesion also involves various signalling intermediates including non-receptor 
tyrosine kinases (non-RTK) such as c-Src, focal adhesion kinase (FAK) and paxillin (Geiger 
& Yamada, 2011; Huveneers & Danen, 2010). c-Src may regulate not only increased cell 
growth and survival, but also it may promote cytoskeletal reorganization and decreased 
cell-ECM adhesion and cell-to-cell adhesion, facilitating cell spreading, migration, 
differentiation and transcription (Alper & Bowden, 2005; Guarino, 2010). Importantly, 
studies in diverse human cancer cells have revealed overexpression and /or overactivation 
of EGFRs and c-Src in the absence of ligands (Alper, & Bowden, 2005; Donepudi & Resh, 
2008; Guarino, 2010; Marcotte et al., 2009). Also, increasing evidence indicates that in the 
absence of growth factors the activation of c-Src and tyrosine phosphorylation at 416-419 
residues occurs by direct interaction with the cytoplasmic tail of integrins and that activated 
c-Src phosphorylates EGFR at Tyr845 residue and ErbB2 at Tyr877  residue (Bill et al., 2004; 
Cabodi et al., 2004; Desgrosellier & Cheresh, 2010; Guarino, 2010; Guo et al., 2006; Kim et al., 
2005; Marcotte et al., 2009;  Moro et al., 2002; Streuli & Akhtar, 2009). Interestingly, these 
patterns of phosphorylation in response to adhesion are different from those triggered by 
the binding of EGF (Bill et al., 2004; Cabodi et al., 2004; Moro et al., 2002). However, 
mechanisms involved in c-Src, EGFR and ErbB2 interactions as well as their implications 
have not being completely understood.   
Growth factors can also indirectly influence integrin function by disrupting cell-to-cell 
contacts modulating cell-ECM interaction and therefore facilitating cell migration and 
invasion. Outstandingly, overstimulation signalling of growth factors or aberrant activation 
tyrosine kinases that lead to loss of epithelial apico-basal polarity and cell-to-cell contacts 
have been consistently reported during the epithelial mesenchymal transition (EMT) (Baum 
et al., 2008; Guarino, 2007). Nevertheless, the molecular, cellular, and mechanical aspects by 
which EGF and their receptors exert these actions remain to be elucidated. In the context of 
endothelial cells, there are reports showing that disruption of endothelial cell-cell contacts or 
adherens junctions (AJs) and changes in the reorganization of microtubules (MTs) and actin 
cytoskeleton may occur in response to mechanical injury, shear stress and / or cross talk of a 
variety of growth factors including transforming growth factor-ǃ (TGFǃ), insulin-like 
growth factor II (IGFII), and fibroblast growth factor-2 (FGF-2), and that such events are 
necessary in the transition of endothelial cells to a mesenchymal phenotype (EndoMT) 
(Arciniegas et al., 2007). However, how these factors and intracellular signals induce the 
endothelial transformation is still matter of debate (Arciniegas & Candelle, 2008). Recent 
evidence from studies on EGF and their receptors indicate that ErbB2, which has no known 
ligand, may form heterodimer with EGFR in response to ligands including EGF and TGF-ǂ 
and that this heterodimer is essential during cardiovascular development and angiogenesis 
(Camenisch et al., 2002; Dreux et al., 2006; Fuller et al., 2008; Mukherjee et al., 2006; Negro et 
al., 2004). Moreover, expression of EGF, TGF-ǂ and heparin binding- EGF (HB-EGF) as well 
as their respective receptors EGFR and ErbB2, have been detected in the intimal thickening 
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and medial smooth muscle cells (SMCs) of atherosclerotic lesions, whereas little or no 
presence of these molecules is observed in the cells of healthy vessels (Dreux et al., 2006). 
EndoMT is not only recognized as a phenomenon that occurs during cardiac fibrosis and 
intimal thickening formation observed in atherosclerosis and restenosis but also in heart and 
vascular development (Arciniegas et al., 2000; Mironov et al., 2005), pulmonary arterial 
hypertension (Arciniegas et al., 2007; Morrell et al., 2009; Sakao et al., 2010), cardiac 
(Goumans et al., 2008) and kidney fibrosis (Zeisberg et al., 2008), hyperthrophic scarring (Xi-
Qiao et al., 2009), diabetic nephropathy (Li & Bertram, 2010), and during cancer progression 
(Potenta et al., 2008). However, there are no studies about the specific role of EGF signalling 
pathway in the EndoMT process.  
In view of the above observations, in this study we examined the presence,  organization, 
and spatial distribution of integrin ǃ3 in monolayers of primary embryonic aortic endothelial 
cells adhered to fibronectin (FN) and maintained in the presence of  Ca2+ and in the absence 
of growth factors, considering that integrin ǂvǃ3 is a receptor widely expressed on the apical 
surface of endothelial cells that binds proteins that are normally present in plasma, such as 
FN, vitronectin, fibrinogen and vWf (Bombeli et al., 1998; Soldi et al., 1999).  Given that 
activation of c-Src, EGFR and ErbB2 may occur by association with integrins (Arias-Salgado 
et al., 2003; Bill et al., 2004; Cabodi et al., 2004; Desgrosellier & Cheresh, 2010; Ivaska & 
Heino, 2009; Huveneers & Danen, 2010; Streuli & Akhtar, 2009), we also investigated 
whether the activated forms of these molecules were present in these monolayers. Since 
some soluble growth factors can also indirectly influence integrin function by disrupting 
cell-to-cell contacts modulating cell-ECM interaction and facilitating cell migration and 
invasion events that are considered necessary in the progression of EndoMT (Arciniegas et 
al., 2007; Arciniegas & Candelle, 2008), we also investigated whether EGF and TGF-ǂ as well 
as their activated receptors participate in the EndoMT process and if they were present in 
chicken embryo aortic wall during embryonic days 12-14 (days E12-E14) (stages 38 and 40) 
when intimal thickening is apparent and endothelial transformation occurs. 
2. Materials and methods 
2.1 Embryonic aortic explants 
Fertilized chicken eggs (White leghorn) were obtained from local hatchery (Granja Avicola 
Agropollito, CA, Paracotos, Estado Miranda) and incubated at 37ºC and 60% humidity for 
10-11 days (stages 36 and 37 of development). Embryos were staged according to 
Hamburger & Hamilton (1992). Aortae were dissected in Hank`s balanced salt solution 
without Ca2+  and Mg2+  (Sigma-Aldrich, St. Louis, MO) at 37ºC. For simplicity, this buffer is 
subsequently referred to as HBSS. Aortic segments, approximately 8mm2 in surface area, 
were isolated (distal to the aortic arches) and opened along longitudinal axis. Explants were 
rinsed in HBSS and left in the same buffer 5-10 min before to initiate the assays. 
2.1.1 Endothelial cell adhesion assays 
To determine the effects of calcium (Ca2+) on endothelial cell adhesion, 35mm Petri dishes 
(Nunclon, Delta, IL) were coated with HBSS containing plasma fibronectin (pFN) (25-
50μg/ml) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and incubated at 37ºC for 2 hr in 
a humidified atmosphere consisiting of 5% CO2, and 95% air. The dishes  were then rinsed 
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twice with HBSS, blocked with 2% bovine serum albumin (BSA) (Sigma-Aldrich) in HBSS 
for 1 hr at 37ºC with 5% CO2 and finally washed three times with the same buffer. After that, 
300μl of HBSS containing 0.025% BSA (Sigma-Aldrich), 100μg/ml streptomycin, and 
100U/ml penicillin (GIBCO, Invitrogen, Carlsbad, CA) were added to some dishes and 
incubated at 37ºC with 5% CO2. Other dishes were incubated with 300μl of HBSS 
supplemented with either 2mM CaCl2 (Ca2+) (Sigma-Aldrich) or 2mM EGTA (Sigma-
Aldrich) and incubated at 37ºC with 5% CO2 for 1 hr. Aortic explants were placed with the 
endothelial apical surface down on coated dishes and allowed to adhere for 4 hr at 37ºC 
with 5% CO2 . At the end of this time, 1ml of the corresponding HBSS was gently added to 
each dish. One hour later, the adhered explants were removed with the aid of a thin needle, 
leaving a monolayer of retracted endothelial cells that exhibited zones denuded of cells or 
wounds.  
In order to emphasize the possible role of Ca2+  in the endothelial cell adhesion, some aortic 
explants were incubated on pFN-coated dishes containing either medium 199 containing 
0.025% BSA (Sigma-Aldrich), 100μg/ml streptomycin, 100U/ml penicillin (GIBCO) 
(subsequently referred to as serum-free M199) (SFM199) or SFM199 containing 2mM EGTA 
(Sigma-Aldrich) and maintained as before.  
Monolayers were examined with an inverted microscope (IX70 Olympus, Olympus America 
Inc., Melville, NY). Images were captured using an image editing capture and processing 
software program (Image Pro Plus, Media Cybernetics, Silver Spring, MD). Four 
independent  experiments were performed and each one included at least 15 dishes. 
2.1.2 Cell cultures 
Cell cultures were initiated when the monolayers of endothelial cells adhered to the surface 
of the coated dishes were rinsed five times with HBSS and incubated with SFM199 for 2 hr 
at 37ºC with 5% CO2 . Images were captured using the Image Pro Plus software program. 
2.1.3 Effects of EGF and TGF-α on embryonic endothelial cells 
Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-ǂ) have been 
reported to stimulate cell migration, differentiation, and proliferation in presence or absence 
of serum (Ackland et al., 2003; Ellis et al., 2007). To determine whether EGF or TGF-ǂ 
stimulates endothelial cell separation, detachment, and migration, the medium of some 
monolayers that had been maintained in SFM199 for 2 hr was switched to SFM199 
supplemented with  either recombinant human EGF (100ηg/ml) or recombinant human 
TGF-ǂ (5-10ηg/ml) (R&D Systems, Inc., Minneapolis, MN) and low amount of chicken 
serum (ChS) (0.1%) (Sigma-Aldrich), using 10mM acetic acid as vehicle, and incubated at 
37ºC with 5% CO2 for an additional 6-8 hr period. During this period the images were 
captured each 2 hr using the Image Pro Plus software program. 
2.1.4 Immunofluorescence 
Fixed and permeabilized cells were processed for immunofluorescence as previously 
described (Arciniegas et al., 2005) using the following antibodies: a mouse monoclonal 
antibody (mab) anti-human integrin ǃ3 (GPIIIa, CD61) and a mab anti-chicken integrin ǃ1 
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(Millipore Chemicon Corporation, Billerica, CA), a mouse mab raised against full length 
ǃ-catenin of chicken origin (clone 6F9) (Santa Cruz Biotechnology), a mouse mab raised 
against aminoacids 8-349 of mouse p120-catenin (clone 6H11) (Santa Cruz Biotechnology), 
a mouse mab raised against native chick brain microtubules (clone DM1A) (Santa Cruz 
Biotechnology), a mouse mab raised against a phospho-peptide corresponding to amino 
acids 416-422 of human c-Src (clone 9A6) (Santa Cruz Biotechnology),  and a rabbit 
polyclonal antibody (pab) phospho-FAK (Tyr397) (Sigma-Aldrich). Negative controls 
were performed by omitting the primary antibody incubation step or by using non 
immune serum in place of primary antibody. Immunofluorescence images were captured 
on an inverted microscope confocal laser scanning microscope (CLSM) (Eclipse TE-300 
Nikon) (Nikon Instruments Inc., Melville, NY) equipped with a Nikon objective Plan-Apo 
BC x60, 1.2 wi coupled to a C1-LU2 unit Argon cooled air (488 ηm) laser. This laser unit 
was controlled by a D-eclipse C1 interface. Other immunofluorescence images were 
captured on a IX81 Olympus inverted microscope with the Fluo-View confocal laser 
scanning configuration (CLSM) (Olympus America). Fluorescence intensity was measured 
by using a processing software program (FV10.ASW version 02.01.01.04, Olympus 
America). 
2.1.5 Immunoperoxidase 
Fixed cells were processed for immunoperoxidase as described previously (Arciniegas et al., 
2005) using a rabbit pab raised against a short amino acid sequence containing 
phosphorylated Tyr845 of EGFR of human origin, and a rabbit pab raised against a short 
amino acid sequence containing phosphorylated Tyr877 of ErbB2/Neu of human origin 
(Santa Cruz Biotechnology). The images were captured using the Image Pro Plus software 
program. 
2.1.6 Flow cytometry analysis of phospho-EGFR (Tyr845) and phospho-ErbB2 
(Tyr877) expression in embryonic endothelial cells  
We evaluated by flow cytometry the expression of phospho-EGFR (Tyr845) and phospho-
ErbB2 (Tyr877) in monolayers of endothelial cells that were maintained in SFM199 for 2 hr 
and  monolayers whose medium was switched to SFM199 supplemented with either rhEGF 
(100ηg/ml) or rhTGF-ǂ (5-10ηg/ml) (R&D Systems) and low-ChS (0.1%) (Sigma-Aldrich) 
and incubated for an additional 6-8 period. Briefly, supernatants from cultures were 
removed, and the cells were harvested and incubated in permeabilizing buffer. After 
incubation, the cells were resuspended in PBS-0.1% BSA containing a rabbit pab anti-human 
phospho-EGFR (Tyr845) or a rabbit pab anti-human phospho-ErbB2 (Tyr877) (Santa Cruz 
Biotechnology). Negative control staining reactions were performed by incubating the cells 
with nonimmune rabbit Ig. After two washes with PBS, the cells were fixed with 1% 
paraformaldehyde in PBS. Data collection and analysis of the fluorescence intensities were 
carried out using a FACScalibur (Becton-Dickinson, San  Jose, CA). Ten thousand events 
were acquired (excluding cell debris) and analyzed using the CELLQuest software program. 
2.1.7 Tissue extraction 
The aortae were dissected from 12-and 14-day-old embryos (stages 38 and 40 of 
development). The excised aortae were placed in HBSS (Sigma-Aldrich), and fixed for 20 
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min at room temperature with 4% formaldehyde prepared from paraformaldehyde (Sigma-
Aldrich) in PBS. The aortae were dehydrated in graded ethanol and embedded in paraffin. 
Paraffin sections (5μm thick) were mounted on silanized slides (Dako North America, Inc., 
Carpinteria, CA). A total of nine aortae for each stage obtained from four different lots of 
fertilized chicken eggs, were processed. 
2.1.8 Immunoperoxidase 
For histological detection of EGF, TGF-ǂ, EGFR and ErbB2/Neu the following antibodies 
were used on deparaffinized sections: a neutralizing antibody anti-human EGF and  
anti-TGF-ǂ, both produced in goat (R&D Systems), a rabbit pab raised against a peptide 
mapping at the C-terminus of EGFR of human origin, and a rabbit pab raised against  
a peptide mapping at C-terminus of Neu of human origin (Santa Cruz Biotechnology). 
Negative controls were produced by the use of purified normal serum or PBS in place  
of primary antibody. The images were captured using the Image pro Plus software 
program. 
3. Results 
In order to determine the effect of Ca2+ on adhesion of embryonic endothelial cells to FN 
aortic explants from days E10 and E11 (stages 36 and 37) were placed with the endothelial 
apical surface down on dishes coated with pFN and containing HBSS alone or HBSS 
supplemented with 2mM Ca2+ and incubated for 5 hours. 
Once the explants were removed, monolayers of endothelial cells that were transiently 
mechanically altered during the explant removal and therefore exhibited zones denuded of 
cells or wounds, were found adhered to the surface of the pFN-coated dishes that contained 
HBSS supplemented with Ca2+ (Fig. 1b), but not on the dishes that contained HBSS alone 
(Fig. 1a).  
To emphasize the possible role of Ca2+ in the endothelial cell adhesion, aortic explants were 
incubated on pFN-coated dishes containing SFM199 or SFM199 containing 2mM EGTA to 
chelate extracellular Ca2+. Like other culture medium, M199 is known for containing Ca2+ 
and relatively low levels of Mg2+. When the explants were removed, monolayers of retracted 
endothelial cells exhibiting zones that were denuded of cells or wounds were found adhered 
to the surface of the pFN-coated dishes that contained SFM199 (Fig. 1c), but not on dishes 
that contained SFM199 and EGTA (Fig. 1d). When the endothelial cell monolayers were 
maintained in the presence SFM199 for 2-3 hr and examined, we observed that they adopted 
a contact inhibited cobblestone-like appearance of polygonal cells. Under this culture 
condition neither migrating cells from the wounded edges nor spreading, separating, 
detaching nor migrating cells from edges of the monolayer were observed (Figs. 2a, b). 
However, when, after this interval, the medium of some cultures was switched to SFM199 
containing EGF or TGF-ǂ and low-ChS and maintained for an additional 6-8 hr period, the 
polygonal cells from along wounds edges appeared to move toward each other extending 
lamellipodia into denuded area, whereas the cells located at the marginal edges of the 
monolayer appear to lose its cobblestone appearance, spreading, separating, detaching and 
migrating toward cell-free areas (Figs. 2c,d).  
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HBSS  HBSS + 2mM Ca2+ 
 
 
 
SFM199  SFM199 + 2mM EGTA 
 
 
Fig. 1. Phase-contrast images captured when the aortic explants that had been incubated on 
pFN-coated dishes containing a) HBSS alone, b) HBSS supplemented with 2mM Ca2+, c) 
SFM199 alone, and d) SFM199 supplemented  with 2mM EGTA were removed after 5 hr. 
Note that only when the explants were incubated with HBSS supplemented with Ca2+ and 
with SFM199 alone monolayers of endothelial cells were found adhered to the surface of the 
dish after removal. Scale bar: 150μm. 
Immunofluorescence analyzed by confocal microscopy determined that in the SFM199 
condition in which the endothelial cells displayed a cobblestone appearance and no 
spreading, separating, detaching, migrating cells were observed, ǃ-catenin and p120 catenin, 
proteins considered as regulators of VE-cadherin function, were localized at cell-cell 
contacts or AJs with MTs emanating from the microtubule organizing center (MTOC), 
organized radially and some of them oriented perpendicular to the cell edge probably 
interacting with sites of cell-cell contacts (Akhmanova et al., 2009) (Figs. 3a-c). Whereas in 
the EGF or TGF-ǂ and low-ChS condition where spreading, separating, detaching and 
migrating cells are observed, the distribution of ǃ-catenin and p120-catenin was disrupted at 
the cell-cell junctions and the organization of MTs was altered (Figs. 3d-f). Specifically, MTs 
were found oriented parallel to the long axis of the cell and the MTOC on the side of the cell 
facing the leading edge (Fig. 3f). Interestingly, ǃ-catenin was also detected in the nucleus of 
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some separating, detaching and migrating cells (Fig. 3d). This location indicates that 
translocation of ǃ-catenin from plasma membranes to the nucleus may also occur in 
response to EGF or TGF-ǂ and low-ChS. These observations indicate that the presence of 
Ca2+ in the absence of growth factors would represent an important requirement to promote 
the adhesion and the eventual organization of explanted embryonic endothelial cells into 
monolayers forming AJs, whereas the addition of EGF or TGF-ǂ and ChS may lead to the 
loss of cell-cell contacts, detachment, and cell migration; in other words, to the loss of 
endothelial cell polarity. 
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Fig. 2. Serie of phase-contrast images of a monolayer of endothelial cells adhered  
to the surface of the pFN-coated dish maintained in SFM199 and switched to SFM199 
supplemented with EGF and low-ChS. a) time zero, shows a monolayer of  retracted 
endothelial exhibiting zones denuded of cells or wounds after removing the explant.  
b) Time 2hr. Cells adopted a cobblestone appearance where neither spreading,  
separating, detaching nor migrating cells from the edges are observed. c) Time 4hr.  
cell spreading, separating detaching and migration are observed when the medium  
of the same culture was switched and maintained for additional 2hr (4hr).  
d) Time 6hr. Cells from the wound moving toward each other extending lamellipodia  
into denuded area. Detail of “d” showing migrating cells. Scale bar: 150μm;  
inset 40μm. 
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Fig. 3. Representative CLSM fluorescence images of ǃ-catenin, p120-catenin, and MTs 
localization in monolayers of endothelial cells adhered to pFN. 
(a-c) Immunolocalization after 2hr in culture in SFM199. (d-f) Immunolocalization in 
monolayers whose medium was switched to medium containing EGF and low-ChS and 
maintained for additional 4hr (6hr). In this condition where spreading, separating, 
detaching and migrating cells are observed, the distribution of ǃ- and p120-catenins is 
disrupted in the cell-cell junctions and the organization of MTs is altered. Note that  
ǃ-catenin is also detected in the nucleus and cytoplasm of some cells.  
a), b), c), f) Scale bar = 30μm; d), e) scale bar = 25μm. 
3.1 Endothelial cell adhesion to FN in the presence of Ca2+ and in the absence of 
serum or growth factors is mediated by integrin β3, and addition of EGF or TGF-α 
produces changes in the distribution and organization of integrin β3 
As the cell-ECM adhesion in the presence of divalent cations such as Ca2+ and Mg2+ is 
actually correlated with the activation, organization and spatial distribution of particular 
integrins in normal and tumor cells (Cierniewska-Cieslak et al., 2002; Cluzel et al., 2005; 
Leitinger et al., 2000; Luo & Springer, 2006) and as integrin ǂvǃ3  is a receptor widely 
expressed on the apical surface of endothelial cells that binds proteins that are normally 
present in plasma, such as pFN, vitronectin, fibrinogen and vWf (Bombeli et al., 1998; Soldi 
et al., 1999), we then examined the presence, organization and distribution of integrin ǃ3 by 
immunofluorescence staining in monolayers of retracted endothelial cells that were found 
adhered to pFN after removal of the explants and incubated with SFM199 for 2-3  hr as well 
as in those whose medium was switched to medium containing EGF or TGF-ǂ and low-ChS 
and maintained for an additional 6-8 hr period. 
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Examination of the monolayers maintained in SFM199 revealed that integrin ǃ3 , in addition 
to be localized on the apical surface, also appeared distributed delineating the margins of 
the cells that had adopted a cobblestone appearance (Fig. 4a). When the medium was 
switched to medium containing EGF or TGF-ǂ and low-ChS the location and distribution of 
integrin ǃ3 appeared altered (Fig. 4b). Specifically, this receptor was found delineating the 
margin of some cells and organized into linear streaks and a punctuate pattern typical of 
focal adhesions in the leading edge of the cells that were spreading, separating, detaching 
and migrating (Fig. 4b). 
These observations suggest  that the adhesion to Fn and eventual organization of embryonic 
endothelial cells in the presence of Ca2+ and in the absence of serum or growth factors may 
be mediated by integrin ǃ3 and that the presence of  EGF or TGF-ǂ and low-ChS would 
produce changes in the spatial distribution and organization of this receptor. 
 
 SFM199  SFM199 + EGF + ChS 0.1% 
Integrin-β3 
 
Fig. 4. a) Overlay of transmission and green fluorescence images of integrin ǃ3 in a 
monolayer of endothelial cells adhered to pFN after 2 hr in culture in the presence of 
SFM199. Integrin ǃ3 is seen on the apical surface and delineating the margin of many cells 
that displayed a cobblestone appearance.  b) CLSM fluorescence image of integrin ǃ3  in a 
monolayer whose medium was switched to medium containing EGF and low-ChS. Integrin 
ǃ3  is seen delineating the margin of some cells and organized into linear streaks and a 
punctuate pattern at the leading edge of the migrating cells. Scale bar: 50μm. 
3.1.1 Immunolocalization of integrin β1 and phospho-FAK in vitro 
Focal adhesions  are considered not only as structural and dynamics links between the ECM 
and the actin cytoskeleton controlling cell shape, spreading, and migration but also as sites 
for signal transduction through integrins such as integrin ǃ1 and ǃ3, and adaptor proteins 
such as FAK and paxillin that are present in these sites (Geiger & Yamada, 2011; Gu et al., 
2011; Mitra et al., 2005). We therefore examined the presence and organization and 
distribution of  integrin ǃ1 and FAK when the medium was switched to medium containing 
EGF and low-ChS. Immunolocalization with anti-integrin ǃ1 and anti-phospho-FAK 
(Tyr397)  revealed that both proteins appeared delineating the margin of some cells and 
organized into linear streaks typical of focal adhesions at leading edge of the cells that were 
separating, detaching and migrating (Figs. 5a,b). 
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Fig. 5. Representative CLSM fluorescence images of integrin  ǃ1 and phospho-FAK in 
monolayers of endothelial cells adhered to pFN after 8 hr in culture in the presence of EGF 
and low-ChS. 
a) Integrin ǃ1 and b) phospho-FAK are seen delineating the margin of some cells and 
organized into arrays typical of focal adhesions at the leading of the migrating cells. a) Scale 
bar: 5μm; b) scale bar 10μm. 
3.1.2 Partial activation of EGFR/ErbB1 and ErbB2/Neu mediated by integrin β3 is 
increased by addition of EGF or TGF-α and low-ChS 
Increasing evidence suggest that the adhesion mediated by integrins can promote the 
recruitment and partial activation of certain RTKs including EGFR and ErbB2/Neu in the 
absence of serum or growth factors  after cell-matrix adhesion (Desgrosellier & Cheresh, 
2010; Ivaska & Heino, 2010; Streuli & Akhtar, 2009; Yamada & Even-Ram,2002); therefore, 
we also investigated whether activated EGFR and ErbB2 were present in monolayers of  
embryonic endothelial cells adhered  to pFN-coated dishes that were incubated in SFM199 
for 2-3 hr and switched to SFM199 supplemented with EGF or TGF-ǂ and low-ChS and 
maintained for an additional 6-8 hr period. Under these conditions the expression of both 
activated EGFR and ErbB2 was investigated by immunoperoxidase staining using anti-
phospho-EGFR (Tyr845) and anti-phospho-ErbB2 (Tyr877). In the SFM199 condition, 
phospho-EGFR and phospho-ErbB2 staining was mostly localized in sites of cell-cell 
contacts. In addition, perinuclear and nuclear staining for these receptors suggestive of 
activation, internalization and nuclear translocation was observed in some cells of the 
monolayer that had adopted a cobblestone appearance (Figs. 6a,b). Remarkably, in the 
EGF or TGF-ǂ and low-ChS condition, strong perinuclear and nuclear staining for 
phospho-EGFR was detected in many cells of the monolayer, as well as in many 
spreading, separating, detaching and migrating cells; whereas in the cell-cell contacts the 
staining appears disrupted (Fig. 6c). For phospho-ErbB2, less intense nuclear staining was 
found in many endothelial cells of the monolayer and spreading, separating, detaching 
and migrating cells. In this condition the staining for ErbB2 in the sites of cell-cell contacts 
also appeared disrupted (Fig. 6d). No immunolabeling was observed when a non immune 
serum was used as negative control and when the primary antibody was omitted (not 
shown). 
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Phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877) expression was confirmed by flow 
cytometry in some cultures (Fig. 7). This technique revealed a relatively elevated expression 
of phospho-EGFR and phospho-ErbB2 in the presence of EGF or TGF-ǂ and low-ChS, in 
contrast to that detected in SFM199. 
Taken together, these observations would suggest that the partial phosphorylation or 
activation of EGFR and ErbB2 mediated by integrin ǃ3 can be increased by addition of EGF 
or TGF-ǂ and low-ChS. 
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Fig. 6. (a,b) Immunolocalization of phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877) in 
monolayers of endothelial cells adhered to pFN after 2hr in culture in the presence of 
SFM199. Staining for both receptors is detected in sites of cell-cell contacts as well as in the 
nucleus and perinuclear region of some cells of the monolayers. (c,d) Immunolocalization of 
phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877) in monolayers whose medium were 
switched to medium containing EGF and low-ChS and maintained for additional 4hr (6hr). 
Strong nuclear and perinuclear staining for phospho-EGFR (Tyr845) is observed in many 
separating, detaching and migrating cells whereas in the cell-cell contacts the staining 
appears disrupted. For phospho-ErbB2 less intense nuclear staining is detected in many 
cells. Note that the staining at the sites of cell-cell contacts also appears disrupted. 
Scale bar: 50μm.  
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Fig. 7. Effect of TGF-ǂ on phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877)  
expression 
Expression of phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877) analyzed by  
flow cytometry in embryonic endothelial cells that were maintained for 2hr in SFM199, 
and in embryonic endothelial cells where the medium was switched to SFM199 
supplemented with TGF-ǂ and low-ChS and cultured for additional 4hr (6hr). Negative 
controls were stained with the respective isotype. Histograms show expression (after 
substracting the background) of phospho-EGFR (Tyr845) and phospho-ErbB2 (Tyr877) by 
SFM199 (black profile) or TGF-ǂ treated (opened histograms) embryonic endothelial cells. 
Results are representative of at least three independent experiments, all of which had 
similar results. 
3.1.3 In vitro phospho-c-Src (Tyr416) immunolocalization 
Recent in vitro studies have indicated that after the adhesion of cells to the ECM, the 
cytoplasmic tail of integrin ǃ3 can directly interact with c-Src promoting its activation and 
that activated c-Src in turn phosphorylates ErbB2 at Tyr877 residue (Marcotte et al., 2009); 
therefore, we also investigated whether the activated c-Src was present in monolayers of 
endothelial cells when they were maintained in SFM199 and when they were switched to 
medium containing EGF and low-ChS. Immunolocalization with  anti-phospho-c-Src 
(Tyr416 in chicken) showed that in the SFM199 condition this non-RTK was also localized at 
the cell-cell contacts or AJs (Fig. 8a) whereas in the EGF and low-ChS condition, phospho-c-
Src appeared aligned with MTs and organized into linear streaks typical of focal adhesion 
complexes at the leading edge as well as in the nucleus of some cells that were separating, 
detaching and migrating (Fig. 8b). 
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Fig. 8. a) CLSM fluorescence image of phospho-c-Src (Tyr416) in a monolayer of endothelial 
cells adhered to pFN after 2hr in culture in the presence of SFM199. Phospho-c-Src is seen in 
the cell-cell contacts. b) CLSM fluorescence image of phospho-c-Src (Tyr416) in a monolayer 
whose medium was switched to medium containing EGF and low-ChS. Phospho-c-Src 
(Tyr416)  appears aligned with MTs and organized into linear streaks at the leading edge of 
separating, detaching and migrating cells. Note that this non-RTK is also detected in the 
nucleus of some cells. Scale bar: 15μm.  
3.1.4 In vivo EGF, TGF-α, EGFR, and ErbB2 immunolocalization 
In view of the above in vitro findings, we evaluated EGF, TGF-ǂ, EGFR and ErbB2/Neu by 
immunoperoxidase staining in the aortic wall at days E12-E14 (stages 38-40) of development 
when intimal thickening is apparent and EndoMT occurs (Arciniegas et al., 2000). 
 
EGF TGF-α EGFR ErbB2/Neu 
   
Fig. 9. Immunolocalization of EGF, TGF-ǂ, EGFR, and ErbB2/Neu in deparaffinized sections 
of chicken embryo aorta at day E14 of development.  
Immunoreactivity for EGF is observed in the endothelial cells (e) and some mesenchymal cells 
(mc) and in cells of the lamellar layers (lc). For TGF-ǂ, a less immunoreactivity is observed in 
the endothelial cells (e) and some mesenchymal cells (mc) and cells of the lamellar layers (lc). 
Strong ErbB2/Neu and moderate EGFR immunoreactivities are detected in most endothelial 
cells (e) and mesenchymal cells (mc) and lamellar cells (lc). L, lumen. Scale bar = 125μm. 
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At days E12-E14, the aortic wall is composed by the endothelium, which limits the vessel 
lumen, and radially oriented mesenchymal cells originating from the endothelium that 
constitute the intimal thickening. At these stages it is possible to distinguish cells organized 
in circular lamellar and interlamellar layers. The immunoreactivity observed at these stages 
for EGF was more intense compared to TGF-ǂ. Even so, both immunoreactivities were 
detected at the endothelial cells and in some mesenchymal cells of the intimal thickening as 
well as in those arranged in lamellar layers (Fig. 9). Immunoperoxidase staining also 
revealed strong ErbB2/Neu and moderate EGFR immunoreactivities in most endothelial 
and mesenchymal cells and those arranged in lamellar layers (Figs. 9). No immunoreactivity 
was observed when the primary antibody was omitted or replaced by non immune serum in 
control sections (not shown).   
4. Discussion 
This study provides evidence that allows us to suggest that the adhesion to pFN of 
explanted embryonic endothelial cells is mediated by integrin ǃ3 and promoted by Ca2+ and 
that the organization of  these cells into monolayers of polarized cells, when they were 
maintained in the absence of serum or growth factors, was established by adhesion to FN 
and by formation of endothelial cell-cell contacts or AJs.The latter involving presence of ǃ-
catenin and p120-catenin, redistribution of integrin ǃ3 and importantly, reorganization of 
MTs with the possible participation of some tyrosine phosphatases and tyrosine kinases 
(Dejana et al, 2009). These cellular events are considered as relevant for the maintenance of 
endothelial cell shape and apico-basal polarity in vitro and during embryonic development 
(Bryant & Mostov, 2008; Dejana et al, 2008; 2009; Iruela-Arispe & Davis, 2009). Remarkably, 
the adhesion to pFN and organization of the endothelial cells into monolayers of polarized 
cells involving formation of AJs and reorganization of MTs in the absence of serum or 
growth factors was accompanied by tyrosine phosphorylation in the kinase domain of EGFR 
and ErbB2 and the nuclear translocation of both receptors. In fact, phosphorylated EGFR 
and ErbB2 were detected at sites of cell-cell contacts and in the nucleus of some cells of the 
monolayers by using anti-phospho EGFR (Tyr845) and anti-phospho ErbB2 (Tyr877). In this 
respect, phosphorylated EGFR has been  detected during the formation of cell-cell contacts 
in monolayers of epithelial cells deprived of serum and maintained in presence of Ca2+, 
suggesting a ligand independent activation of EGFR induced by its interaction with E-
cadherin or with components of the AJs (Erez et al., 2005; Pece & Gutkind, 2000; Takahashi 
et al., 1997). It is noteworthy that basolateral localization of EGFR and ErbB2 along with 
components of the AJs has been consistently reported in polarized epithelial cells (Borg et 
al., 2000; Feigin & Muthuswamy, 2009; Hoschuetzky et al., 1994; Shelly et al., 2003; Tanos & 
Rodriguez-Boulan et al., 2008). Also, studies in epithelial cancer cells have indicated that the 
formation of AJs mediated by E-cadherin induces activation of EGFR in the absence of 
ligand leading to elevation of anti-apoptotic members of Bcl-2 family of regulatory proteins 
to protect cells from the apoptosis (Shen & Kramer, 2004). 
Activated EGFR and ErbB2 have also been observed in the nucleus of human fetal 
endothelial cells (Bueter et al., 2006) and in normal and tumor epithelial cells suggesting that 
these receptors may regulate gene activation and transcription and possibly other nuclear 
events (Giri et al., 2005; Wang et al., 2010).  In this sense, it is known that binding of 
integrins to their ligands in the absence of serum or growth factors can promote cell survival 
by increasing Bcl-2 transcription (Matter & Ruoslahti, 2001; Zhang et al., 1995) and that 
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clustering and occupancy of integrins in the absence of growth factors can also provoke 
recruitment and partial activation of several RTKs including members of the  EGFR family 
(Desgrosellier & Cheresh, 2010; Eliceiri, 2001; Huveneers & Danen, 2010;  Ivaska & Heino, 
2010; ;  Streuli & Akhtar, 2009; Yamada & Even-Ram, 2002). For instance, in epithelial cell 
lines, and human endothelial cells line ECV304, adhesion to FN mediated by integrin ǃ1 in 
the absence of serum or growth factors produces a rapid phosphorylation of EGFR at 
Tyr845, 1068, 1086, and 1173 residues that results critical for their survival (Bill et al., 2004; 
Cabodi et al., 2004; Moro et al., 2002). These levels of phosphorylation are lower than that 
observed with EGF. Importantly, phosphorylation of Tyr845 residue in the kinase domain of 
EGFR has been shown requires c-Src tyrosine kinase which is activated after integrin-
mediated cell adhesion and autophosphorylated at Tyr419 residue of its kinase domain 
(Tyr416 in chicken) (Bill et al., 2004; Cabodi et al., 2004). Others have found that 
phosphorylation of Tyr877 residue in the kinase domain of ErbB2 is dependent on activated 
and phosphorylated c-Src (Tyr419) (Marcotte et al., 2009; Rivas et al., 2010; Xu et al., 2007). 
Some of them suggesting that activated and phosphorylated c-Src specifically associates 
with ErbB2, but not with other EGFR family members (Kim et al., 2005; Marcotte et al., 2009; 
Muthuswamy & Muller, 1995).  
In view of above observations, we also investigated the presence and distribution of c-Src in 
the absence of serum or growth factors. Of note, c-Src phosphorylated at Tyr416 residue was 
localized at sites of cell-cell contacts or AJs displaying a pattern similar to that observed for  
ǃ-catenin and p120-catenin and integrin ǃ3. To this respect, there is evidence showing that 
activated c-Src participates during the cell-ECM adhesion and formation of cell-cell 
adhesions where it might phosphorylate ǃ-catenin and p120-catenin regulating certain 
signalling pathways that are considered as essentials for cell survival (Guarino, 2010; 
Schlessinger, 2000). Of interest, studies have shown that adhesion of osteoclast precursors to 
FN or vitronectin induces c-Src and MTs association and that this association affects the 
polarity of osteoclasts (Abu-Amer et al., 1997). Also, studies have revealed reciprocal 
interactions between c-Src and EGFR in the absence of growth factors (Donepudi & Resh, 
2008). One of them, suggesting that autonomus c-Src activation may cause activation of 
EGFR, mimicking the effects of low concentration of EGF on EGFR activation, redistribution, 
and signalling (de Diesbach et al., 2010). In this context, previous studies have shown that 
clustering of integrin ǃ3 by ligands such as FN can result in the recruitment and activation of 
c-Src, inducing phosphorylation of Tyr416 or 419 residues in its kinase domain (Arias-
Salgado et al., 2003; Desgrosellier et al., 2009; Guarino, 2010; Huveneers & Danen, 2010) and 
that activated and phosphorylated c-Src in turn phosphorylates ErbB2 at Tyr877 residue 
(Marcotte et al., 2009). Interestingly, these patterns of phosphorylation are different from 
those triggered by the binding of EGF. 
Thus, we believe that, in the absence of serum or growth factors, the adhesion of 
explanted embryonic endothelial cells to pFN, mediated by activation and clustering of 
integrin ǃ3, promotes the activation of c-Src which is found associated with MTs and that 
activated c-Src contributes to the formation of endothelial cell-cell contacts or Ajs by 
phosphorylation of ǃ-catenin and p120-catenin. This process would be accompanied by 
the EGFR and ErbB2 phosphorylation  at the Tyr845 and Tyr877 residues respectively, 
leading to the partial activation and nuclear translocation of both receptors with 
consequent regulation of Bcl-2 proteins expression to protect cells from the apoptosis 
induced by serum-deprivation.  
www.intechopen.com
Integrin-Mediated Endothelial Cell Adhesion and Activation of c-Src,  
EGFR and ErbB2 are Required for Endothelial-Mesenchymal Transition 
 
41 
In this study, we found that the closure of the wounds (re-endothelialization) was almost 
complete and that endothelial cell spreading, separation, detachment and migration also 
took place at the marginal edges of the monolayers when the medium of some cultures was 
switched to medium containing EGF or TGF-ǂ and low amount of ChS (0.1%). These 
observations are consistent with the possibility that EGF or TGF-ǂ may be interacting with 
those EGFRs that remain exposed or accessible to ligand in the lateral cell borders after 
removing the explant. EGFR then would heterodimerize with ErbB2 and being internalized 
which results in the disruption of endothelial cell-cell contacts by remodelling of the MTs 
and alterations in the distribution of integrin ǃ3, ǃ-catenin and p120-catenin, and therefore 
mediating the reparation of the wounds and the migration of the cells toward cell-free areas. 
This view is reinforced by previous reports suggesting that mechanical damage of 
monolayers of epithelial cells allows to ErbB2, which localizes on the basolateral surface, to 
interact with its ligand (heregulin) normally secreted to the apical surface leading to 
proliferation, migration and repair of the wound (Mostov & Zegers, 2003; Tanos & 
Rodríguez-Boulan, 2008; Vermeer et al., 2003). Notably, in this study we also found changes 
in the distribution and organization of phospho-c-Src (Tyr416) upon EGF or TGF-ǂ and low-
ChS addition. We believe that such changes may be associated with remodelling of MTs and 
alterations in the distribution of integrins ǃ3 and ǃ1 and ǃ-catenin and p120-catenin during 
the disruption of endothelial cell-cell contacts. Consistent with this, studies in EGF-
stimulated epithelial cells have provided evidence that MTs remodelling induces activation 
of c-Src which then  phosphorylates ǃ-catenin and p120-catenin,  leading to the disruption of 
AJs, cell-ECM adhesion promoting cell migration and invasion (Guarino, 2010). Also of 
significance, cytoskeleton remodelling and loss of cell-cell contacts have been correlated 
with elevated expression of activated c-Src in tumor cells and during the EMT process 
(Alper & Bowden, 2005; Guarino, 2010). In relation to the nuclear localization of phospho c-
Src (Tyr416) observed during EGF stimulation, emerging evidence suggest that nuclear 
localization of Src-family tyrosine kinases, including c-Src, upon growth factor stimulation 
regulates not only tyrosine phosphorylation of nuclear proteins, but also the structure of 
chromatine (Takahashi et al., 2009). In this study, stimulation with EGF or TGF-ǂ also 
showed the localization of phospho-FAK (Tyr397), integrins ǃ3 and ǃ1 at focal adhesion 
when endothelial cell spreading, separation, detachment, and migration occurred. In this 
context, previous studies have shown that clustering of integrins ǃ1, ǃ3, and ǃ5 by ligands 
such as FN or alterations in the cytoskeleton, can result in the recruitment and 
autophosphorylation of FAK at Tyr397 residue and that activated FAK promotes Src 
binding and activation to increase FAK activity leading to the formation an activated FAK-
Src signalling complex (Ilić et al., 2004; Mitra et al., 2005). Same studies propose that this 
activated complex affect not only the assembly and disassembly of focal adhesions, but also 
promotes cell migration through regulation of cytoskeleton and integrin recycling and the 
disruption of adherens junctions (Mitra et al., 2005). Interestingly, integrin recruitment, 
internalization by macropinocytosis and redistribution, have been observed during cell 
migration induced by growth factors (Gu et al., 2011).Thus, we believe that the endothelial 
cell detachment involving assembly and disassembly of focal adhesions and the migration 
observed upon EGF or TGF-ǂ and low-ChS addition would be related with integrins ǃ3 and 
ǃ1 recruitment, internalization and redistribution, and with the activation of FAK and c-Src 
during EGFR and ErbB2 endocytosis. It is known that EGF or TGF-ǂ acts by binding to 
EGFR leading to the receptor homo-or hetero-dimerization, activation of its receptor 
tyrosine kinase cytosolic domain and autophosphorylation on tyrosine residues initiating 
various important signal transduction pathways that could collaborate in the cell adhesion, 
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migration, proliferation, differentiation and survival (Carpenter & Liao 2009; Olayioye et al., 
2000). Upon binding of EGF, receptors clustering and endocytosis take place followed by 
recycling back of the ligand-complex to the cell surface or degradation. After internalization, 
nuclear translocation of the receptors may also occur to regulate gene expression (Giri et al., 
2005; Lemmon, 2009; Roepstorff et al., 2008; Wang et al., 2010; Yarden & Sliwkowski, 2001). 
Of particular interest, stimulation of EGFR endocytosis accompanied by remodelling of MTs 
after addition of EGF has been reported in HeLa cells (Kharchenko et al., 2007). 
In this study, phosphorylation, internalization, and nuclear translocation of EGFR and 
ErbB2 was also observed upon EGF or TGF-ǂ and low-ChS addition. In this condition, flow 
cytometry analysis revealed an increased expression of phosphorylated EGFR and ErbB2, in 
contrast with that detected in the SFM condition or absence of growth factors. Consistent 
with this, previous studies have shown that treatment of endothelial ECV304 cells with EGF, 
increases the levels of phosphorylation of EGFR induced by adhesion to FN and mediated 
by integrin ǃ1 (Cabodi et al., 2004).  Of note, a recent work by Odintsova´s laboratory has 
reported that the integrin-mediated epithelial cell adhesion potentiates the phosphorylation 
of EGFR and ErbB2 induced by EGF or TGF-ǂ facilitating receptor homo-and hetero-
dimerization of these receptors and that this process could be accompanied by actin 
cytoskeleton organization (Alexi et al., 2011). Accordingly, our observations suggest that the 
dimerization, activation and phosphorylation of EGFR and ErbB2, initiated by integrin ǃ3, 
would be increased by addition of EGF or TGF-ǂ, and that  the internalization of these 
receptors could be accompanied by MTs remodelling which induces the activation of c-Src 
and phosphorylation of ǃ-catenin and p120-catenin to promote loss of endothelial cell 
polarity and disruption of cell-cell contacts, facilitating cell spreading, separation, 
detachment, and migration, cellular events considered as essentials in the progression of 
EndoMT.  Interestingly, overexpression and/or activation of EGFRs have been well 
documented to affect epithelial polarization and cell-cell contacts and leads to EMT of 
normal cells (Feigin & Muthuswamy, 2009). However, the precise mechanisms by which 
EGFRs deregulate normal epithelial architecture to promote EMT are incompletely 
understood (Feigin & Muthuswamy, 2009) 
In addition to these findings, this study also provides in vivo evidence that EGF, TGF-ǂ as 
well as their receptors EGFR and ErbB2 were present in those stages of development (days 
E12-E14) where  the intimal thickening are clearly evident and EndoMT is an active process. 
These data are interesting if we consider that in vivo expression of EGF, TGF-ǂ as well as 
their respective receptors have been detected in the intimal thickening and medial smooth 
muscle cells of atherosclerotic lesions (Dreux et al., 2006), and that expression of activated 
ErbB2 and ErbB3 has been demonstrated during heart cushion development (Camenish et 
al., 2002), suggesting an important contribution for these receptors in the initiation of 
atherosclerosis and in the development of cardiac valves, respectively. 
Collectively, our findings suggest that integrin-mediated endothelial cell adhesion and 
activation and translocation of c-Src, EGFR and ErbB2 as well as the presence of their 
ligands are required for EndoMT. 
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